Carboxytherapy for Periorbital Dark Circles

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT05672407` - The Role of Local Tranexamic Acid on Periorbital Oculoplastic Surgery	Phase 4
Completed	`NCT03393624` - Influence of Sleep Quality in Patients With Periorbicular Hyperchromia
Active, not recruiting	`NCT03238105` - Treatment of Periorbicular Hyperchromia Comparing 10% Thioglycolic Acid Peeling Versus Pulsed Intense Light	Phase 4

See also

Status

Clinical Trial

Phase

Withdrawn

NCT05672407 - The Role of Local Tranexamic Acid on Periorbital Oculoplastic Surgery

Phase 4

Completed

NCT03393624 - Influence of Sleep Quality in Patients With Periorbicular Hyperchromia

Active, not recruiting

NCT03238105 - Treatment of Periorbicular Hyperchromia Comparing 10% Thioglycolic Acid Peeling Versus Pulsed Intense Light

Phase 4

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT04745078
Study type	Interventional
Source	Alexandria University
Contact
Status	Completed
Phase	N/A
Start date	January 1, 2017
Completion date	May 15, 2021

Carboxytherapy for Periorbital Dark Circles

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms